Picture of GSK logo

GSK GSK News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - GSK PLC - GSK publishes provisional dividend dates

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251110:nRSJ7689Ga&default-theme=true

RNS Number : 7689G  GSK PLC  10 November 2025

GSK plc

 

GSK publishes provisional dividend dates

 

 

GSK announces the following dividend dates for 2026:

 

 

These dates are indicative and may be subject to change.

 

 

 Results  Announcement date           Ordinary Shares Ex-dividend date  American Depositary Shares Ex-dividend date  Record date              Last date for DRIP elections  Payable
 Q1 2026  Wednesday 29 April 2026                                       Friday 15 May 2026                           Friday 15 May 2026       Thursday 18 June 2026         Thursday 9 July 2026

                                      Thursday 14 May 2026

 Q2 2026  Wednesday 29 July 2026      Thursday 13 August 2026                                                        Friday 14 August 2026    Thursday 17 September 2026    Thursday 8 October 2026

                                                                        Friday 14 August 2026

 Q3 2026                              Thursday 12 November 2026         Friday 13 November 2026                      Friday 13 November 2026  Monday 14 December 2026       Thursday 7 January 2027

          Wednesday 28 October 2026

 Q4 2026                              Thursday 18 February 2027         Friday 19 February 2027                      Friday 19 February 2027  Tuesday 16 March 2027         Thursday 8 April 2027

          Wednesday 3 February 2027

 

 

V A Whyte

Company Secretary

 

 

10 November 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVMZMGMMLMGKZM



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on GSK

See all news